Dioseve
Developer of in vitro egg generation technology designed to create functional human oocytes. The company induces the differentiation of iPS cells into oocyte and ovarian somatic cells at high efficien...
Valuation
$26.3M
Market implied
Share Price
N/A
Total Raised
$20.1M
Last Round
N/A